Effect of angiotensin II receptor blocker, valsartan, on insulin resistance of schizophrenic patients with olanzapine treatment

被引：0
|
作者：
Yamashita, Hakuei
Yoda, Hiroo
Saito, Masashi
Kuwabara, Michiko
Odagaki, Yuji
Kazawa, Tetsushi
Kikuchi, Atsuko
Maruki, Taeko
Toyoshima, Ryoichi
Kawazu, Shoji
机构：
[1] Moro Hosp, Dept Psychiat, Saitama, Japan
[2] Saitama Med Univ, Fac Med, Sch Med, Dept Neuropsychiat, Saitama, Japan
[3] Saitama Med Univ Hosp, Hlth Management Ctr, Saitama, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
O31
引用
收藏
页码：A9 / A10
页数：2
相关论文
共 50 条
  • [21] The angiotensin II type 1 receptor blocker valsartan attenuates graft vasculopathy
    Yamamoto, T
    Sata, M
    Fukuda, D
    Takamoto, S
    BASIC RESEARCH IN CARDIOLOGY, 2005, 100 (01) : 84 - 91
  • [22] Angiotensin II Receptor Blocker, Valsartan, Increases Myocardial Blood Volume and Regresses Hypertrophy in Hypertensive Patients
    Komatsu, Hiroshi
    Yamada, Satoshi
    Iwano, Hiroyuki
    Okada, Masako
    Onozuka, Hisao
    Mikami, Taisei
    Yokoyama, Shinobu
    Inoue, Mamiko
    Kaga, Sanae
    Nishida, Mutsumi
    Shimizu, Chikara
    Matsuno, Kazuhiko
    Tsutsui, Hiroyuki
    CIRCULATION JOURNAL, 2009, 73 (11) : 2098 - 2103
  • [23] ISSUE ON ANGIOTENSIN RECEPTOR BLOCKER VALSARTAN AS APPLIED TO ARTERIAL HYPERTENSION PATIENTS WITH TYPE II DIABETES MELLITUS
    Musayev, Z.
    JOURNAL OF HYPERTENSION, 2018, 36 : E279 - E280
  • [24] Effects of angiotensin II-Receptor blocker, valsartan, on residual renal function in patients on CAPD.
    Kikuta, T
    Watanabe, Y
    Kanno, Y
    Tomori, K
    Nakamoto, H
    Okada, H
    Suzuki, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 482A - 482A
  • [25] Angiotensin II type 1 receptor genotype and response to angiotensin II receptor blocker valsartan in early stage diabetic nephropathy
    Takei, Kako
    Kimura, Tomomi
    Miyazaki, Mitsuhiro
    Matsumoto, Ryuma
    muramatsu, Masaaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 223 - 223
  • [26] Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
    Lee, Hyun Woo
    Suh, Jae Kyung
    Jang, Eunjin
    Lee, Sang-Min
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 371 - 381
  • [27] Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice
    Shiuchi, T
    Iwai, M
    Li, HS
    Wu, L
    Min, LJ
    Li, JM
    Okumura, M
    Cui, TX
    Horiuchi, M
    HYPERTENSION, 2004, 43 (05) : 1003 - 1010
  • [28] Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy
    Oparil, Suzanne
    Giles, Thomas
    Ofili, Elizabeth O.
    Pitt, Bertram
    Seifu, Yodit
    Hilkert, Robert
    Samuel, Rita
    Sowers, James R.
    JOURNAL OF HYPERTENSION, 2011, 29 (01) : 161 - 170
  • [29] The Novel Angiotensin H Receptor Blocker Azilsartan Medoxomil Ameliorates Insulin Resistance Induced by Chronic Angiotensin II Treatment in Rat Skeletal Muscle
    Lastra, Guido
    Santos, Fernando R.
    Hooshmand, Payam
    Hooshmand, Paria
    Mugerfeld, Irina
    Aroor, Annayya R.
    DeMarco, Vincent G.
    Sowers, James R.
    Henriksen, Erik J.
    CARDIORENAL MEDICINE, 2013, 3 (02) : 154 - 164
  • [30] Effect of calcium channel blocker in combination with an angiotensin II receptor blocker in Japanese patients with hypertension
    Saruta, Takao
    DRUGS, 2006, 66 : 19 - 21
12345